Pibrentasvir (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pibrentasvir" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

1foxbusiness.com

2,709^th place

1,537^th place

68^th place

117^th place

doi.org

Ng TI, Krishnan P, Pilot-Matias T, Kati W, Schnell G, Beyer J, et al. (May 2017). "In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir". Antimicrobial Agents and Chemotherapy. 61 (5): e02558–16. doi:10.1128/AAC.02558-16. PMC 5404558. PMID 28193664.

europa.eu

ema.europa.eu

"Maviret: EPAR – Summary for the public" (PDF). European Medicines Agency. 2017-08-17.

foxbusiness.com

Johnson LA (August 3, 2017). "FDA OKs new drug to treat all forms of hepatitis C". Fox Business.

nih.gov

ncbi.nlm.nih.gov

Ng TI, Krishnan P, Pilot-Matias T, Kati W, Schnell G, Beyer J, et al. (May 2017). "In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir". Antimicrobial Agents and Chemotherapy. 61 (5): e02558–16. doi:10.1128/AAC.02558-16. PMC 5404558. PMID 28193664.

pubmed.ncbi.nlm.nih.gov

Ng TI, Krishnan P, Pilot-Matias T, Kati W, Schnell G, Beyer J, et al. (May 2017). "In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir". Antimicrobial Agents and Chemotherapy. 61 (5): e02558–16. doi:10.1128/AAC.02558-16. PMC 5404558. PMID 28193664.